Literature DB >> 21173357

Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.

Judson B Williams1, Elizabeth R Delong, Eric D Peterson, Rachel S Dokholyan, Fang-Shu Ou, T Bruce Ferguson.   

Abstract

BACKGROUND: Despite evidence supporting the use of aspirin, β-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering therapies in eligible patients, adoption of these secondary prevention measures after coronary artery bypass grafting has been inconsistent. We sought to rigorously test on a national scale whether low-intensity continuous quality improvement interventions can be used to speed secondary prevention adherence after coronary artery bypass grafting. METHODS AND
RESULTS: A total of 458 hospitals participating in the Society of Thoracic Surgeons National Cardiac Database and treating 361 328 patients undergoing isolated coronary artery bypass grafting were randomized to either a control or an intervention group. The intervention group received continuous quality improvement materials designed to influence the prescription of the secondary prevention medications at discharge. The primary outcome measure was discharge prescription rates of the targeted secondary prevention medications at intervention versus control sites, assessed by measuring preintervention and postintervention site differences. Prerandomization treatment patterns and baseline data were similar in the control (n=234) and treatment (n=224) groups. Individual medication use and composite adherence increased over 24 months in both groups, with a markedly more rapid rate of adherence uptake among the intervention hospitals and a statistically significant therapy hazard ratio in the intervention versus control group for all 4 secondary prevention medications.
CONCLUSIONS: Provider-led, low-intensity continuous quality improvement efforts can improve the adoption of care processes into national practice within the context of a medical specialty society infrastructure. The findings of the present trial have led to the incorporation of study outcome metrics into a medical society rating system for ongoing quality improvement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21173357      PMCID: PMC3683243          DOI: 10.1161/CIRCULATIONAHA.110.981068

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  22 in total

1.  The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons.

Authors:  T B Ferguson; S W Dziuban; F H Edwards; M C Eiken; A L Shroyer; P C Pairolero; R P Anderson; F L Grover
Journal:  Ann Thorac Surg       Date:  2000-03       Impact factor: 4.330

2.  Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?

Authors:  J Chen; M J Radford; Y Wang; T A Marciniak; H M Krumholz
Journal:  Arch Intern Med       Date:  2000-04-10

3.  AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Authors:  S C Smith; S N Blair; R O Bonow; L M Brass; M D Cerqueira; K Dracup; V Fuster; A Gotto; S M Grundy; N H Miller; A Jacobs; D Jones; R M Krauss; L Mosca; I Ockene; R C Pasternak; T Pearson; M A Pfeffer; R D Starke; K A Taubert
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

4.  Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database.

Authors:  Karl F Welke; T Bruce Ferguson; Laura P Coombs; Rachel S Dokholyan; Cindy J Murray; Mary A Schrader; Eric D Peterson
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

5.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

Authors:  Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce Whitney Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak
Journal:  Circulation       Date:  2004-10-05       Impact factor: 29.690

6.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

7.  Alabama coronary artery bypass grafting project: results of a statewide quality improvement initiative.

Authors:  W L Holman; R M Allman; M Sansom; C I Kiefe; E D Peterson; K J Anstrom; S S Sankey; S G Hubbard; R G Sherrill
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

8.  Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial.

Authors:  C I Kiefe; J J Allison; O D Williams; S D Person; M T Weaver; N W Weissman
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

9.  Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial.

Authors:  T Bruce Ferguson; Eric D Peterson; Laura P Coombs; Mary C Eiken; Meghan L Carey; Frederick L Grover; Elizabeth R DeLong
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

10.  Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001.

Authors:  Stephen F Jencks; Edwin D Huff; Timothy Cuerdon
Journal:  JAMA       Date:  2003-01-15       Impact factor: 56.272

View more
  18 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care study.

Authors:  Judson B Williams; Adrian F Hernandez; Shuang Li; Rachel S Dokholyan; Sean M O'Brien; Peter K Smith; T Bruce Ferguson; Eric D Peterson
Journal:  J Card Surg       Date:  2011-09-26       Impact factor: 1.620

3.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

5.  Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.

Authors:  Javaid Iqbal; Patrick W Serruys
Journal:  Ann Transl Med       Date:  2017-03

6.  Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.

Authors:  John K Roberts; Sunil V Rao; Linda K Shaw; Dianne S Gallup; Oscar C Marroquin; Uptal D Patel
Journal:  Am J Cardiol       Date:  2017-02-09       Impact factor: 2.778

Review 7.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

8.  Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy.

Authors:  Eric J Velazquez; Judson B Williams; Eric Yow; Linda K Shaw; Kerry L Lee; Harry R Phillips; Christopher M O'Connor; Peter K Smith; Robert H Jones
Journal:  Ann Thorac Surg       Date:  2012-02       Impact factor: 4.330

9.  Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting.

Authors:  Judson B Williams; Renato D Lopes; Gail E Hafley; T Bruce Ferguson; Michael J Mack; C Michael Gibson; Robert A Harrington; Eric D Peterson; Peter K Smith; Rajendra H Mehta; John H Alexander
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

10.  Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.

Authors:  Renato D Lopes; Judson B Williams; Rajendra H Mehta; Eric M Reyes; Gail E Hafley; Keith B Allen; Michael J Mack; Eric D Peterson; Robert A Harrington; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; T Bruce Ferguson; Todd J Lorenz; John H Alexander
Journal:  Am Heart J       Date:  2012-09       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.